share_log

Palisade Bio to Present at the Virtual Investor Pitch Conference

Palisade Bio to Present at the Virtual Investor Pitch Conference

Palisade Bio將在虛擬投資人路演會上做演講。
Palisade Bio ·  06/10 12:00

Live video webcast on Monday, June 17th at 12:00 PM ET

週一(6月17日)直播視頻網絡研討會th東部時間下午12:00

Carlsbad, CA, June 10, 2024 — Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade" or the "Company"), biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will present at the Virtual Investor Pitch Conference on June 17, 2024 at 12:00 PM ET.

2024年6月10日,加利福尼亞州卡爾斯巴德市 — Palisade Bio公司。(納斯達克:PALI)Palisade(以下簡稱“公司”)是一家生物製藥公司,專注於開發和推進新型治療自身免疫、炎症和纖維化疾病的藥物。今天宣佈,將於2024年6月17日美國東部時間下午12:00在患者優先臨床試驗峯會上演講。虛擬投資者路演會議2024年6月17日美國東部時間下午12:00。

As part of the event, J.D. Finley, Chief Executive Officer of Palisade Bio, will provide an "elevator pitch" and outline the Company's upcoming milestones. Additionally, investors and interested parties will have the opportunity to submit questions live during the event. Participating companies will answer as many questions as possible in the time allowed.

作爲本次活動的一部分,Palisade Bio首席執行官J.D. Finley將提供一個“電梯演講”,並概述公司即將到來的里程碑。此外,投資者和有興趣的人將有機會在活動期間實時提交問題。參與公司將在允許的時間內回答儘可能多的問題。

A live video webcast of the presentation will be available on the Events page of the Investors section of the Company's website (www.palisadebio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About Palisade Bio
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

關於Palisade Bio
Palisade Bio是一家生物製藥公司,專注於開發和推進新型治療自身免疫、炎症和纖維化疾病的藥物。該公司相信,通過使用其新型治療方法,將改變治療局面。有關詳細信息,請訪問公司網站www.palisadebio.com.

Investor Relations Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
PALI@jtcir.com

投資者關係聯繫人
JTC團隊有限責任公司
Jenene Thomas
833-475-8247
PALI@jtcir.com

Primary Logo

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論